News Focus
News Focus
icon url

jesster64

12/09/25 12:00 PM

#801957 RE: NotSure2 #801955

SP went to .40, almost 2x, on no news, just stuttgart holding. Even without NICE funding people will flock to UK for treatment to save their lives. Gofundme can help with that. The alternative is death in 12 months. NICE has been in contact with NWBO for a while now. They must realize dc-vax is cheaper, more effective, and no side effects, so why not approve funding.
icon url

sukus

12/09/25 12:05 PM

#801960 RE: NotSure2 #801955

Just compare it with other smaller biotechs. You will know. Those biotech companies not even in phase 1. They just announced they wanted to do such and such. They just tried the MOA in mice. But they already have lofty valuation.

If they can have very rich valuation, how about NWBO? Of course NWBO can too. Therefore if you dare, if you are informed, this extremely undervalued valuation will not stay too long. I believe.

The market eventually will use the correct weighing machine for NWBO and others who can prove themselves that they are real companies supported by data and capacity to serve the market.

IMO.